Question 1

What was the tested purity of lot CRTZ-30-2604-1?

Accepted Answer

Lot CRTZ-30-2604-1 (Double Agonist) tested at 99.950% HPLC purity from Crush Research, based on 1 Certificate of Analysis indexed by Disclosed Labs.

Question 2

Which lab tested lot CRTZ-30-2604-1?

Accepted Answer

Lot CRTZ-30-2604-1 was tested by ILS Labs based on COA data in the Disclosed Labs corpus.

Question 3

Was lot CRTZ-30-2604-1 tested for endotoxin?

Accepted Answer

Yes — lot CRTZ-30-2604-1 has at least one COA reporting an endotoxin (LAL) result: NMT 0.05 EU/mL. Endotoxin testing (USP <85> / LAL) is a safety panel that matters for injectable compounds.

CRTZ-30-2604-1

Tests reported